Alcon Free Cash Flow 2019-2025 | ALC

Alcon free cash flow for the twelve months ending March 31, 2025 was , a year-over-year.

  • Alcon annual free cash flow for 2024 was $1.604B, a 119.73% increase from 2023.
  • Alcon annual free cash flow for 2023 was $0.73B, a 25.65% increase from 2022.
  • Alcon annual free cash flow for 2022 was $0.581B, a 9.92% decline from 2021.

Alcon Free Cash Flow 2019-2025 | ALC

  • Alcon annual free cash flow for 2024 was $1.604B, a 119.73% increase from 2023.
  • Alcon annual free cash flow for 2023 was $0.73B, a 25.65% increase from 2022.
  • Alcon annual free cash flow for 2022 was $0.581B, a 9.92% decline from 2021.
Related Stocks
Company NameMarket
Cap
Intuitive Surgical (ISRG)$185.9B
Thermo Fisher Scientific (TMO)$156.6B
Edwards Lifesciences (EW)$44.9B
IDEXX Laboratories (IDXX)$41.4B
DexCom (DXCM)$32.9B
IQVIA Holdings (IQV)$27.8B
Mettler-Toledo (MTD)$24.8B
STERIS (STE)$22.2B
SONOVA HOLDING (SONVY)$17.4B
Waters (WAT)$17.1B
Hologic (HOLX)$14.3B
Sysmex ADR (SSMXY)$10.4B
Penumbra (PEN)$8.9B
Masimo (MASI)$8.4B
Globus Medical (GMED)$7.6B
Glaukos (GKOS)$5.6B
Teleflex (TFX)$4.9B
Integer Holdings (ITGR)$3.9B
TransMedics (TMDX)$3.7B
PROCEPT BioRobotics (PRCT)$3.2B
LivaNova (LIVN)$2.3B
Elekta AB (EKTAY)$1.9B
Nihon Kohden (NHNKY)$1.9B
Veracyte (VCYT)$1.8B
Alphatec Holdings (ATEC)$1.5B
Artivion (AORT)$1.3B
Paragon 28 (FNA)$1.1B
OPKO Health (OPK)$1.1B
Pulse Biosciences (PLSE)$1B
Tandem Diabetes Care (TNDM)$984M